HOME › Research Insight › Key Players in the Oligonucleotide Synthesis Market Focus on New Product Launches, Expansions, Acquisitions and Agreements, Collaborations, and Partnerships to Hold Market Position
Key Players in the Oligonucleotide Synthesis Market Focus on New Product Launches, Expansions, Acquisitions and Agreements, Collaborations, and Partnerships to Hold Market Position
Prominent players in the oligonucleotide synthesis market are Agilent Technologies, Inc. (U.S.), BioAutomation Corporation (U.S.), BioSearch Technologies, Inc. (U.S.), Eurofins Genomics (Germany), Eurogentec (Belgium), GE Healthcare (U.K.), Glen Research (U.S.), Gene Link, Inc. (U.S.), GenScript USA, Inc. (U.S.), GeneDesign, Inc. (Japan), Integrated DNA Technologies, Inc. (IDT) (U.S.), Link Technologies, Ltd. (U.K.), Nitto Denko Avecia, Inc. (U.S.), Sigma-Aldrich Co. LLC. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and TriLinkBioTechnologies, Inc. (U.S.)
The oligonucleotide synthesis market is a moderately consolidated market, divided into various segments. Each segment possesses different market players and leaders. For instance, the equipment market was led by BioAutomation Corporation (U.S.) in 2013. The company’s MerMade synthesizers are widely used for oligonucleotide synthesis. BioAutomation offers a full line of DNA/RNA oligonucleotide synthesizers as well as custom models to scientists and researchers in the field of biotechnology so as to cope with their changing requirements.
After acquiring Life Technologies, Thermo Fisher Scientific strengthened its oligonucleotide product portfolio. Thermo Fisher Scientific, Inc. (U.S.) led the oligonucleotide synthesis reagents market in 2013. The company has a wide product portfolio that includes primers, probes, reagents, phosphoramidites, and custom oligos. The companyleverages its strong brand name and market presence in the market to gain a competitive edge. The company is innovation-centric and invests heavily in R&D. Moreover, it possesses a strong sales force, which helps it to sell its products efficiently. The company believes in growth both organic and inorganic for enhancing its market position.
The key strategies followed by most companies in the oligonucleotide synthesis market are new product launches, agreements, collaborations, and partnerships, acquisitions, and expansions. Among all growth strategies being adopted by players in this field, agreements, collaborations, and partnerships, and acquisitions accounted for the largest share of the overall growth strategies mapped from 2011 to 2014. Some leading players adopting these strategies are BioAutomation Corporation (U.S.),Eurofins Genomics (Germany) andGE Life Sciences (U.S.). Expansionsaccounted for the second largest share of the overall growth strategies adopted by players in the market.
Oligonucleotide Synthesis Market by Product & Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User (Research, Pharmaceutical & Biotechnology), Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) - Global Forecast to 2019
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252